ArticleNeuroradiology2012
Continuing the search for MR imaging biomarkers for MGMT promoter methylation status: conventional and perfusion MRI revisited.
Article in Neuroradiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Magnetic resonance imaging fractal analysis of O(6)-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase wild-type glioblastoma.Quantitative imaging in medicine and surgery · 2025Article
- Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma.Cancers · 2023Article
- Validation of MRI-Based Models to Predict MGMT Promoter Methylation in Gliomas: BraTS 2021 Radiogenomics Challenge.Cancers · 2022Article
- Radiological model based on the standard magnetic resonance sequences for detecting methylguanine methyltransferase methylation in glioma using texture analysis.Cancer science · 2021Article
- Predictive markers for MGMT promoter methylation in glioblastomas.Neurosurgical review · 2019Article
- Imaging scoring systems for preoperative molecular diagnoses of lower-grade gliomas.Neurosurgical review · 2019Article
- Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.European radiology · 2018Article
- Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.BMC cancer · 2018Article
- MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2018Article
- Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status.Journal of digital imaging · 2017Article
- MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas.Medical physics · 2016Article
- Potential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastoma.AJNR. American journal of neuroradiology · 2013Article
- Prediction of MGMT promotor methylation status in glioblastoma by contrast-enhanced T1-weighted intensity image.Neuro-oncology advancesArticle
Corrections and comments
- Comment on
Authors and funding
7 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.